Details of the Drug

General Information of Drug (ID: DMMJC1Y)

Drug Name

CHML

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 3	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	A phase II clinical trial with cytotropic heterogeneous molecular lipids (CHML) for patients with hepatic malignancies. Anticancer Res. 2007 May-Jun;27(3B):1593-600.